Retinal neurodegeneration in type II diabetic Otsuka long-evans Tokushima fatty rats

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 6, 2013, Pages 3844-3851

  Yang, Ji Ho ^a   Kwak, Hyung Woo ^a   Kim, Tae Gi ^a   Han, Jisang ^a   Moon, Sang Woong ^a   Yu, Seung Young ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Diabetic retinopathy; Neurodegeneration; OLETF

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HISTOLOGY; MALE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NERVE DEGENERATION; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

DIABETIC RETINOPATHY; NEURODEGENERATION; OLETF;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; LONGITUDINAL STUDIES; MALE; NERVE FIBERS; RATS; RATS, INBRED OLETF; REGRESSION ANALYSIS; RETINAL DEGENERATION; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84878642787     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11309     Document Type: Article

References (34)

1. Engerman RL, Kern TS. Retinopathy in animal models of diabetes. Diabetes Metab Rev. 1995;11:109-120.
2. Barber AJ, Lieth E, Khin SA, Antonetti DA, Bchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. J Clin Invest. 1998;102:783-791.
3. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology. 1998;95:693-698.
4. Feitosa-Santana C, Paramei GV, Nishi M, Gualtieri M, Costa MF, Ventura DF. Color vision impairment in type 2 diabetes assessed by the D-15d test and Cambridge colour test. Ophthalmic Physiol Opt. 2010;30:717-723.
5. Frost-Larsen K, Larsen HW, Simonsen SE. Oscillatory potential and nyctometry in insulin-dependent diabetics. Acta Ophthal-mol. 1980;58:879-888.
6. Martin PM, Roon P, Smithe SB, Ganapathy V, Van Ells TK. Death of retinal neurons in streptozocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330-3336.
7. Barber AJ, Antonetti DA, Kern TS, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210-2218.
8. Park SH, Park SJ, Kim KY, Chung JW, Oh SJ. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetoglia. 2003;46:1260-1268.
9. Rossini AA, Appel MC, Williams RM, Like AA. Genetic influence of the streptozocin-induced insulinitis and hyper-glycemia. Diabetes. 1977;26:916-920.
10. Villarroel M, Ciudin A, Hernandez C, Simo R. Neurodegener-ation: an early event of diabetic retinopathy. World J Diabetes. 2010;15:57-64.
11. Kawano K, Hirashima T, Moris S, Saito Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992;41:1422-1428.
12. Nagai N, Murao T, Ito Y, Okamoto N, Okamura H. Involvement of interleukin 18 in lens opacification of Otsuka Long-Evans Tokushima Fatty rats, a model of human type 2 diabetes. Curr Eye Res. 2011;36:497-506.
13. Maeda K, Segawa Y, Asai H, Shirao Y, Sounou T, Yamada A. Changes in electroretinograms of spontaneously diabetic rats. Folia Ophthalmol Jpn. 1997;48:851-854.
14. Miyamura N, Bhutto IA, Amemiya T. Retinal capillary changes in Otsuka Long-Evans Tokushima Fatty Rats (spontaneously diabetic strain). Ophthalmic Res. 1999;31:358-366.
15. Lu ZY, Bhutto IA, Amemiya T. Retinal changes in Otuska Long-Evans Tokushima Fatty rats (spontaneously diabetic rat)- possibility of a new experimental model for diabetic retinop-athy. Jpn J Ophthalmol. 2003;47:28-35.
16. Hirashima T, Kawano K, Mori S, Matsumoto K, Natori T. A diabetogenic gene (0DB-1) assigned to the X-chromosome in OLETF rats. Diabetes Res Clin Pract. 1995;27:91-96.
17. Ruggeri M, Webbe H, Jiao S, et al. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2007;48:1808-1814.
18. Lozano DC, Twa MD. Quantitative evaluation of factors influencing the repeatability of SD-OCT thickness measurements in the rat. Invest Ophthalmol Vis Sci. 2012;53:8378-8385.
19. Kieckle FL, Zhang Z. Apoptosis: biomechanical aspects and clinical implications. Clin Chim Acta. 2002;326:27-45.
20. Nagata A, Higashide T, Ohkubo S, Takeda H, Sugiyama K. In vivo quantitative evaluation of the rat retinal nerve fiber layer with optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50:2809-2815.
21. Margo CE, Lee A. Fixation of whole eyes: the role of fixative osmolarity in the production of tissue artifact. Graefes Arch Clin Exp Ophthalmol. 1995;233:366-370.
22. Garbriele ML, Ishikawa H, Schuman JS, et al. Reproducibility of spectral-domain optical coherence tomography total retinal thickness measurements in mice. Invest Ophthalmol Vis Sci. 2010;51:6519-6523.
23. Hughes A. A schematic eye for the rat. Vision Res. 1979;19: 569-588.
24. Kawaguchi I, Higashide T, Ohkubo S, Takeda H, Sugiyama K. In vivo imaging and quantitative evaluation of the rat retinal nerve finer layer using scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci. 2006;47:2911-2916.
25. Cavallotti C, Artico M, Pescosolido N, Fehe J. Age-related changes in rat retina. Jpn J Ophthalmol. 2001;45:68-75.
26. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003;52:506-511.
27. Shinoda K, Reidak R, Schuettauf F, et al. Early electroretino-graphic features of streptozocin-induced diabetic retinopathy. Clin Experiment Ophthalmol. 2007;35:847-854.
28. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res. 2002;74:615-625.
29. Segawa Y, Shirao Y, Yamagishi S, et al. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy. Ophthalmic Res. 1998;30:333-339.
30. Lieth E, Barber AJ, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes. 1998;47:815-820.
31. Kowluru RA, Engerman RL, Case GL, Kern TS. Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int. 2001;38:385-390.
32. Park JW, Park SJ, Park SH, et al. Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina. Neurobiol Dis. 2006;21:43-49.
33. Feit-Leichman RA, Kinouchi R, Takeda M, et al. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci. 2005; 46:4281-4287.
34. Barber AJ. A new view of diabetic retinopathy: a neurodegen-erative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283-290.